Future studies will be needed to determine if EV heterogeneity and CD24-mediated regulation of EV surface protein composition is generalizable to other B cell lymphomas, healthy B cells, or other CD24-expressing cells. The gene discussed is PROS1; the disease is B-cell non-Hodgkin lymphoma.